Joseph Clemente
Internal Medicine · Warren, NJNPI 1326129586
Payments from drug & device makers
Across 275 payments — averaging $12.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$495
- Amarin Pharma, Inc.$460
- AbbVie$442
- AstraZeneca$313
- Astellas Pharma US Inc$300
- Lilly USA, LLC$238
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,406100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $495 |
| Amarin Pharma, Inc. | 42 | $460 |
| AbbVie(2 entities) | 48 | $442 |
| AstraZeneca | 22 | $313 |
| Astellas Pharma US Inc | 17 | $300 |
| Lilly USA, LLC | 21 | $238 |
| Merck | 17 | $215 |
| Boehringer Ingelheim | 11 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $131 |
| Intuitive Surgical | 1 | $91 |
| Amgen(2 entities) | 6 | $82 |
| Pfizer | 5 | $62 |
| Teva Pharmaceuticals USA, Inc. | 5 | $60 |
| BD | 1 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Novartis | 3 | $39 |
| Avanir Pharmaceuticals, Inc. | 3 | $38 |
| Abbott | 2 | $34 |
| Johnson & Johnson | 2 | $27 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Esperion Therapeutics, Inc. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| GSK | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
How this compares
$3,420 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $68,852 |
| JardianceEmpagliflozin | 50 | $40,174 |
| EliquisApixaban | 48 | $38,153 |
| JanuviaSitagliptin Phosphate | 39 | $31,367 |
| Diclofenac Sodium | 62 | $21,842 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $19,010 |
| TrulicityDulaglutide | 16 | $15,224 |
| XareltoRivaroxaban | 14 | $14,162 |
| Victoza 3-PakLiraglutide | 13 | $9,918 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $9,551 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 36 | $9,001 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 67 | $8,134 |
| Victoza 2-PakLiraglutide | 14 | $7,431 |
| Atrovent HfaIpratropium Bromide | 13 | $5,986 |
| FiaspInsulin Aspart (Niacinamide) | 14 | $5,752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Fiasp | $495 | $74,60479 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $142 | $49,72563 claims |
| PfizerEliquis | $62 | $38,15348 claims |
| MerckJanuvia | $215 | $31,36739 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $15 | $24,22028 claims |
| Lilly USA, LLCTrulicity | $238 | $15,22416 claims |
| Johnson & JohnsonXarelto | $27 | $14,16214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Warren
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
- Helio PedroNewark$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.